Hospitalogy May 23, 2025
The next frontier of value-based care is, of course, value-based specialty care (VBSC). We know the stats around the opportunity and level of spend present in downstream specialty care segments. In my ‘2024 state of value-based care enablement’ piece in 2024, I talked about several companies in the value-based specialty care game across kidney care, MSK, oncology, and…cardiology.
Despite a tighter capital environment in recent memory, VBSC companies have managed to attract large rounds by pointing to the immense savings possible in specialty care. We’re talking nine-figure raises and unicorn valuations for several kidney and multi-specialty players, and solid eight-figure rounds in oncology and MSK. Strategic investors (payors, provider incumbents) are also betting on these startups or forming joint ventures,...







